Skip to main content
. 2017 Aug 15;17:547. doi: 10.1186/s12885-017-3527-7

Table 2.

DLTs according to dose levels

Dose level Number of Assessable patients Bevacizumab
(Q2W)
Pazopanib (Q.D) Number of DLT
DL1 9 7.5 mg/kg 400 mg No DLT
DL1 Confirmatory Cohort 6 3 DLT:- 2 grade 3 MAHAb
- 1 grade 3 ALT/AST
DL2 10a 7.5 mg/kg 600 mg 5 DLT:- 2 grade 3 ALT/ASTc
- 1 grade 3 pulmonary embolismc
- 2 grade 3 MAHAc

a1 patient dropped out for non-authorized dose reduction at week 5

bMAHA: Microangiopathic & hemolytic anemia

coccurred in one nephrectomized patient